Cathie Wood Abb Vie Inc. Transaction History

Ark Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $58.1 Million - $66 Million	-546,411 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $705,538 - $786,010	-6,706 Reduced 1.21%	546,411 $61.5 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $56.6 Million - $62.3 Million	553,117 New	553,117 $59.9 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.